[ HOW-TO GUIDE ]

How to Respond to an FDA Warning Letter

Answer a warning letter completely, within its deadline, and work toward a close-out letter.

What a how-to is not

A how-to is SPEQ’s practitioner method, not a procedure. It does not replace your own SOP, it is not a validated approach, and the judgement calls in it belong to your quality unit.

A warning letter means FDA considers the violations significant enough to lead to enforcement if they are not promptly and adequately corrected. It sets its own response period, usually 15 working days, and tells the firm what the response must contain. A close-out letter follows only when FDA has verified the correction. This is the path from receipt to close-out.

WORK THROUGH THESE STEPS IN THE TEMPLATE
FDA 483 and Warning Letter Response
Each step below has a place in SPEQ’s structured, regulator-aligned template for this procedure. Open the template →
THE STEPS
  1. 1

    Read the letter for its instructions

    Note the response period, the official the response goes to, every violation cited, and whether FDA acknowledged the 483 response and judged its corrective actions adequate. The letter usually asks for a response within 15 working days of receipt.

  2. 2

    Re-open the 483 response critically

    Where the letter says earlier corrective actions were inadequate, find out why — scope too narrow, root cause not reached, no evidence, no effectiveness check — before writing anything new.

  3. 3

    Answer exactly what the letter asks

    For each violation give every step taken or to be taken to correct it and prevent recurrence, the time to complete each, the reason any action cannot be completed within the response period, and the documentation showing correction.

  4. 4

    Address the wider consequences

    Drug letters citing CGMP may say export certificates and, where appropriate, new application approvals may be withheld; device letters may say certificates to foreign governments may not be granted, and Class III premarket approvals can be held. Plan for these alongside the correction itself.

  5. 5

    Disagree with evidence, if you disagree

    Warning letters usually invite the firm to explain, with supporting evidence, why it believes it is not in violation. Use that route for genuine factual disputes, and answer every other item in full.

  6. 6

    Work toward verified close-out

    A close-out letter issues only after FDA verifies, usually at a follow-up inspection, that the corrections were made and finds no other significant violations. Keep the evidence ready, report progress, and remember that the letter stays posted on FDA’s site; the firm may ask FDA to post its response too.

COMMON PITFALLS
  • !Treating the warning letter as a longer 483 response, rather than as prior notice before enforcement.
  • !Answering only some of the violations, or answering without documentation.
  • !Missing the stated response period without explaining the delay.
  • !Assuming the close-out letter ends the obligation: if later inspections find the corrections did not hold, FDA treats those violations as serious.
REGULATORY BASIS
GO DEEPER

How to Respond to an FDA Warning Letter: frequently asked questions

Common questions on respond to an fda warning letter.

Is a warning letter final agency action?

No. FDA’s Regulatory Procedures Manual describes the warning letter as informal and advisory: it communicates the agency’s position but does not commit FDA to enforcement, and FDA does not consider it final agency action. An inspection that leads to a warning letter is classified Official Action Indicated.

Will FDA remove the warning letter from its website after close-out?

No. FDA does not remove warning letters unless it rescinds or amends them. It posts a notice when a close-out letter is issued, and the firm may ask FDA to post its response to the warning letter.

Can FDA act without a warning letter first?

Yes. FDA is under no general legal obligation to warn before enforcement. Its Regulatory Procedures Manual lists situations where it may act without one, including repeated violations after notice, intentional or flagrant violations, and violations that present a reasonable possibility of injury or death.

RELATED HOW-TO GUIDES
All 127 guides →

WHERE NEXT

  1. DO ITOpen the FDA 483 and Warning Letter Response template →The structure these steps fill in.
  2. UNDERSTAND ITResponding to an FDA 483 and a Warning Letter →The principles behind the procedure.
  3. ALL GUIDESBrowse all 127 how-to guides →

A free account keeps what you save, remembers where you are across devices, and can send you the weekly regulatory briefing. Create a free account